Clinical Trial Update: My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the My-HyperCVAD regimen for adults with relapsed or refractory acute lymphoblastic leukemia. The current trial status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• My-HyperCVAD

Snippet

Sponsor: University of Bologna | Conditions: Lymphoid Leukemia | Phase 2 | Status: UNKNOWN